Bragar eagel & Squire, P.C. Encourages Investors too Contact the Firm Regarding Potential Securities Class action Lawsuits Against Telix Pharmaceuticals and Firefly Aerospace
NEW YORK, NY - November 28, 2023 – Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential securities class action lawsuits on behalf of investors in Telix Pharmaceuticals Limited (TLX) and Firefly aerospace, Inc. Investors who purchased shares of either company are encouraged to contact the firm before upcoming deadlines to protect their legal rights.
These investigations center on potential violations of federal securities laws.For Telix Pharmaceuticals, the firm is examining claims concerning potential misstatements and omissions regarding the company’s business and financial results. Firefly Aerospace investors are being evaluated for potential claims related to disclosures concerning the company’s financial condition and operations. Lead plaintiff deadlines are approaching, requiring investors to act promptly to perhaps participate in any recovery.
Telix Pharmaceuticals (TLX) Inquiry Details: Investors with details about Telix Pharmaceuticals are urged to contact Bragar Eagel & Squire, P.C. The firm is evaluating potential claims concerning whether Telix Pharmaceuticals made false or misleading statements to investors.
Firefly Aerospace Investigation Details: Bragar Eagel & Squire, P.C. is also investigating Firefly Aerospace, Inc. Investors who purchased shares of Firefly Aerospace are encouraged to reach out to the firm.The investigation concerns potential misrepresentations and omissions related to the company’s financial standing and business practices.
Investors are encouraged to contact Bragar Eagel & Squire,P.C.to discuss their legal options and learn more about these investigations.
Contact Information:
Bragar Eagel & Squire,P.C.
Brandon Walker, Esq.
Melissa Fortunato, Esq.
(212) 355-4648
investigations@bespc.com
www.bespc.com
Investors can also follow Bragar Eagel & Squire, P.C. on Facebook, LinkedIn, and X for updates and further information.
